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Abstract: The clinical outcomes from 14 children (7 male) with cystic fibrosis (CF) who had a gastrostomy tube inserted 
between January 1999 and August 2005 are presented. The mean age of gastrostomy insertion was 6.63 years. All patients 
had pancreatic insufficiency with mildly compromised lung function (mean FEV1 71%). Data was collected for 1 year 
prior and 2 years post commencement of gastrostomy feeding. Subjects experienced a significant decline in both weight 
and height for the 12 months prior to enteral feeding. There was a significant improvement in some anthropometric 
parameters but not respiratory function in the first 12 months of feeding which then plateau during the second year. These 
results also highlight the benefit of using height and weight Z scores rather than the measuring of the BMI as an indicator 
of nutritional change in children with CF. 
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INTRODUCTION 
  Children with cystic fibrosis (CF) commonly fail to 
thrive secondary to increased energy requirements associated 
with chronic respiratory infection, anorexia, inadequate 
dietary intake, maldigestion and malabsorption [1]. Despite 
significant improvements in treatment, malnutrition still 
remains prevalent within the CF population. Nutritional 
repletion and intervention involving prescription of energy-
dense foods and fluids, optimisation of pancreatic enzyme 
replacement therapy (PERT), oral supplements and enteral 
feeding  via  gastrostomy may be required depending on 
preferences [2]. 
  Few studies have assessed the efficacy of gastrostomy 
feeding or re-feeding malnourished children with CF [1, 3-6] 
and the Cochrane Systematic review reported no randomised 
controlled trials [7]. 
  Due to the extensive geographical area that forms the 
State of Queensland in Australia, the Royal Children’s 
Hospital in Brisbane (RCH) clinic operates a model of 
‘shared care’ with regional hospitals. This model enables 
specialist care to be provided which has been well 
documented to enhance outcomes for patients [8] while 
enabling patients access to local health care providers. The 
specialists from the CF team visit the regional centres every 
6 months. Procedures such as the insertion of gastrostomy 
tubes, all occur at the RCH with all travelling costs   
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reimbursed to the family. Individual insurance status is not a 
determinant of access to care. 
  The aim of this study was to explore the long term effects 
of gastrostomy feeding on clinical, pulmonary and 
nutritional parameters during childhood. Secondary 
objectives were to benchmark our clinic practice with the 
recommendations documented in the Australasian Clinical 
Practice Guidelines for Nutrition in CF (2006) [9] and to 
evaluate the role of shared care on nutritional outcome. 
METHODOLOGY 
  This case series of all fourteen children with a confirmed 
diagnosis of CF and who had a gastrostomy placed between 
January 1999 and August 2005 at the RCH, Brisbane were 
included in this retrospective review. As this was a 
retrospective case chart review, formal Ethical approval was 
not required. One subject had moved from another state and 
their pre-gastrostomy data were collected from their hospital 
of origin, 3 were part of ‘shared care’ arrangements so data 
available at regional centres was accessed in order to 
complete the dataset. Anthropometric and respiratory 
parameters, including height, weight, body mass index 
(BMI) and forced expiratory volume in one second (FEV1) 
were collated at 6 month intervals over a three year period: 
one year pre-gastrostomy insertion and for the two years 
after gastrostomy tube insertion. To allow comparison 
between age and gender, Z scores were calculated using 
CDC reference standards and the LMS method [10]. FEV1 
was not available for children under the age of 6 years and 
BMI was not calculated for children under the age of 2 years 
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  The number of RCH hospitalisations within the 3 year 
period were counted and reported annually. Further 
information regarding mode of diagnosis, cystic fibrosis 
related diabetes, glucose intolerance, pancreatic 
insufficiency, presence of significant liver disease (as 
defined by the presence of portal hypertension, hepatic 
fibrosis or cirrhosis), chronic infection with Pseudomonas 
aeruginosa and other medical conditions were collected for 
each patient by review of medical records. Information 
regarding the presence of co-morbidities, commencement of 
oral supplements, nasogastric feeding, age and reasons for 
gastrostomy placement, type of gastrostomy, complications 
associated with gastrostomy, age and reason for ceasing 
gastrostomy feeding and dietary prescription (type and 
frequency of formula prescribed) were also documented. 
Statistical Analysis 
  The effect of gastrostomy feeding upon nutritional status 
(height, weight, BMI) and pulmonary function (FEV1) were 
evaluated using the paired t-tests and over time using a 
repeated measure ANOVA and ANCOVA to explore the 
interaction with covariates such as gender and age. Data was 
analysed using SPSS version 14.0 and results deemed to be 
statistically significant when p<0.05. 
RESULTS 
  Data was collected of 14 patients (7 male, 7 female) with 
a gastrostomy tube in situ within the defined dates. The 
median age at the time of gastrostomy insertion was 6.63 
years (0.42 – 13.0 years). All patients were pancreatic 
insufficient and were receiving pancreatic replacement 
therapy (PERT). CFTR mutations are documented in Table 
1. 
Table 1.  Genotype and Co-Morbidities of the Children with 
Gastrostomy Tubes 
 
F508/F508 8 
F508/unknown 1 
F508/G551D 1 
G551D/R1126X 1 
CFTR Genotype 
Unknown 3 
CF related diabetes  2  Co-morbidities 
Significant liver disease  4 
 
  Of the 5 children less than 2 years of age, all were 
homozygous delta F508, 4/5 were infected with 
Pseudomonas aeruginosa, two out of five had been 
diagnosed with meconium ileus and all children had 
documented evidence of very early feeding difficulties such 
as problems with the introduction of solid foods. 
Reasons for the Commencement of Gastrostomy Feeding 
  In children over the age of 2 years (n = 9), in the year 
prior to insertion of gastrostomy tube there were significant 
declines in Z scores for weight (t = 2.4, p = 0.02) and height 
(t = 2.7, p = 0.04) but not BMI (t = 1.6, p = 0.15). 
Respiratory function as defined by FEV1 (n = 7) declined 
but not significantly (t = 2.1, p = 0.08). 
  The documented reasons for commencement of overnight 
gastrostomy feeding included failure to thrive (weight and 
height crossing percentiles with a downward trajectory), 
poor oral intake and/or failure to meet their increased 
nutritional requirements. Prior to gastrostomy insertion, 10 
(71%) patients received oral supplementary nutrition such as 
fortified breast milk or formulae or oral supplements such as 
high energy milkshakes. The majority (86%) of patients 
continued to receive oral supplements after gastrostomy 
insertion. Eight (57%) had received enteral nutrition via the 
nasogastric route prior to the gastrostomy tube being placed. 
Enteral feeding provided included whole protein commercial 
products containing 1 or 1.5 kcal/ml. Pancreatic enzymes 
were given in an individually tailored dose titrated against 
the fat content of the feed to be delivered with half taken as 
the feed commenced and half at the end of the feeding period 
[11]. The frequency of the overnight gastrostomy feeding 
plan ranged from five to seven times/week and aimed to 
provide one third to one half of estimated energy 
requirements. Maintenance of normal daytime intake of food 
and drink was encouraged. 
Type of Gastrostomy and Complications 
  Two (14%) patients had cystic fibrosis related diabetes 
(CFRD) and were being treated with insulin and four (29%) 
patients had symptoms of significant liver disease. Of these, 
one had been diagnosed with CFRD and one was diagnosed 
with liver disease after gastrostomy feeding had commenced 
(see Table 1). 
 Documented complications associated with the 
gastrostomy included granulation tissue at the gastrostomy 
site, itchiness, redness and infection, and diarrhoea and 
reflux associated with feeding. None of the complications 
were severe enough to warrant holding or cessation of 
overnight feeding during the 3 year audit period. Seven 
(50%) of children had a Nissan fundoplication at the time of 
gastrostomy placement. No child died during the 3 year 
period of interest. 
Effect of Gastrostomy Feeding Over Time 
  During the first 12 months of overnight feeding there 
were non-significant changes in Z score for height (t = 1.703, 
p = 0.112), weight (t = -0.735, p = 0.475) but a significant 
gain in BMI (t = -3.278, p = 0.01). FEV1 remained stable (t 
= 0.885, p = 0.405) (see Table 2). 
  During the second year of feeding (12 – 24 months), 
nutritional gains were less evident with no significant change 
in anthropometric indices: Z score for height (t = -0.418, p = 
0.683), weight (t = 0.619, p = 0.546) or BMI (t = 1.766, p = 
0.108). FEV1 remained stable (t = 0.714, p = 0.498). 
 Fig.  (1) shows the changes in weight, height and BMI Z 
scores over time in children over the age of 2 years. 
  To examine changes over time and their relationship with 
age and respiratory function at the time of commencement of 
feeding, a repeated measures ANCOVA with age and 
baseline FEV1 as separate cofactors were used. This 
demonstrated that from the time of commencement of 
gastrostomy feeding to post 24 months, there were no 
significant change in Z score for weight, height or BMI with 
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  To examine if there was any differences in outcomes in 
those receiving shared care compared to those who only 
attended the specialist centre (RCH), an independent t test was 
performed examining differences in Z scores for weight, height, 
BMI and FEV1 from baseline to 12 months post insertion of 
gastrostomy tube: there were no significant differences in any 
parameter. 
Pulmonary Function 
  Using paired t tests, from baseline to 12 months, FEV1 
remained stable (t 0.88, p = 0.4) and this stability continued 
during the second year of gastrostomy use (t 0.7, p = 0.5). Using 
a repeated measures analysis from 1 year pre insertion to 2 years 
post, there was a significant decline (mean 16.7%) in FEV1 (F1,6 
= 442, p<0.001), with the main decline (mean 15%) occurring 
in the 12 months pre- to 12 months post gastrostomy insertion (t 
= 3.45, p = 0.01; See Table 2). 
DISCUSSION 
  This analysis using a case series approach sought to explore 
the effect of our clinical practice which aims to prevent 
malnutrition and the spiral decline in lung function by early 
nutritional intervention. During the 12 months prior to initiation 
of gastrostomy feeding, weight and height decreased indicating 
a decline in nutritional status which acted as an impetus for 
insertion of a gastrostomy tube. Supplementing oral food and 
drink was tried in 93% of children prior to the use of overnight 
feeding which when instigated provided up between one third 
and one half of energy requirements with titration of PERT. 
Thus our findings support our adherence to the recently revised 
Australasian Clinical Practice Guidelines for Nutrition in CF 
[9]. 
  Relative to other published studies evaluating the outcomes 
of gastrostomy feeding [1, 4], our population had only modest 
levels of pulmonary compromise at the time of commencement 
of overnight feeding (mean FEV1 71%). Our relative success in 
maintaining nutritional status may be linked to the fact that less 
success can be expected when enteral feeding is introduced in 
those with greater respiratory compromise (FEV1 <40-50%) 
when it may be difficult to enhance energy intake to counter 
balance the energy and protein needs of respiration and 
inflammation [3, 4]. 
Table  2. Change in Anthropometric and Respiratory 
Parameters Over 3 Years for All Subjects (n = 14) 
 
Height Z scores  Pre (1 year)  -0.69 (0.92) 
mean (SD)  Baseline  -0.50 (1.19) 
 Post  (1  year)  -0.85 (1.03) 
 Post  (2  years)  -0.78 (0.85) 
Weight Z scores  Pre (1 year)  -1.11 (0.64) 
mean (SD)  Baseline  -1.20 (0.82) 
 Post  (1  year)  -1.05 (0.73) 
 Post  (2  years)  -1.15 (0.92) 
BMI Z scores  
(n = 9) 
Pre (1 year)  -0.75 (0.64) 
mean (SD)  Baseline  -1.13 (0.61) 
 Post  (1  year)  -0.56 (0.62) 
 Post  (2  years)  -0.98 (1.01) 
FEV1 (%) n = 7  Pre (1 year)  82.97 (6.10) 
mean (SD)  Baseline  71.02 (13.53) 
 Post  (1  year)  67.26 (17.54) 
 Post  (2  years)  66.28 (14.73) 
Number of  
hospitalisations 
Pre (1 year) – Baseline  3.08 (1.50) 
mean (SD)  Baseline – Post (1 year)  3.21 (2.33) 
  Post (1 year) – Post (2 years)  3.30 (1.83) 
Pre (1 year) = 12 months pre-gastrostomy insertion; Baseline = time of gastrostomy 
insertion; 
Post (1 year) = 12 months post-gastrostomy insertion; Post (2 years) = 24 months post-
gastrostomy insertion; BMI = body mass index; FEV1 = forced expiratory volume in 
one second (%). 
 
  In this group of children with mild respiratory compromise 
(as defined by mean FEV1% 71% at baseline) it is notable that 
FEV1 continued to decline despite intensive nutritional support. 
The timing of loss of lung function is important to pin-point as 
our results suggests that respiratory decline could follow a 
period of poor nutrition and although nutrition can be stabilised 
by enteral feeding, respiratory function does not return to the 
same extent. The timing of commencing aggressive nutrition 
intervention needs to be further defined and suggest that more 
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Fig. (1). Changs in height, weight and BMI Z scores in children > 2 years over time (mean ± SE). Gastrostomy Feeding in Cystic Fibrosis  The Open Respiratory Medicine Journal, 2009, Volume 3    115 
accurate measures of body composition change rather than 
using the blunt instruments that standard anthropometric 
measures offer. It has been reported that in adults with CF, lean 
body mass is highly correlated with lung function [12]. 
Therefore determination of change in lean body mass such as by 
total body potassium measurement or dual energy x-ray 
absorbometry would help identify those where loss of lean body 
cell mass indicates the need for aggressive nutrition support. 
Earlier intervention would perhaps lessen the interactions 
between inflammation, infection and malnutrition. 
  This case series demonstrate that FEV1 remained relatively 
stable during the 2 years after the initiation of gastrostomy 
feeding. However, the deficit of lung function is not recovered 
despite some improvements to nutritional status to the level it 
was 12 months prior to starting supplementary feeding. This 
suggests that even earlier intervention may need to be 
considered. Recently, additional daily growth hormone 
treatment alongside enteral feeding has been demonstrated to 
improve clinical status as well as nutritional status [13]. 
  Our findings do point to the need to inform patients and 
caregivers that huge and visually obvious gains in nutritional 
status should not be expected as a result of long term overnight 
feeding. Some evidence suggests that caregivers have a greater 
expectation of weight improvement than are often experienced 
[14] and, anecdotally our experience is that compliance and 
motivation with this additional time consuming treatment 
regimen tends to decline with time. More work is needed in 
patient reported outcomes of gastrostomy feeding and the 
impact it has on family functioning. It is pleasing that in a 
geographically diverse spread of patients, those receiving shared 
care have similar outcomes to those who attend only a regional 
centre. 
  These results also highlight the benefit of using height and 
weight Z scores rather than the measure of BMI as an indicator 
of nutritional change. As BMI is derived from height and 
weight, use of BMI as an indicator of nutritional failure masks 
those whose general linear growth is falling away from normal 
expected rates. BMI should not be used on its own as a measure 
of nutritional status in children with CF as it can provide a 
misleading view of nutritional status in CF. 
  In conclusion, gastrostomy feeding appears to be well 
tolerated without major complications in young children with 
CF whose nutritional status is declining. During the first year, 
the greatest gains in height and weight were seen with a 
levelling of these in the second year of feeding. Further research 
is needed to pinpoint markers that indicate when the instigation 
of invasive feeding methods may help to protect respiratory 
function, especially in younger children. 
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ABBREVIATIONS 
CF   =   Cystic Fibrosis 
FEV   =   Forced Expiratory Volume 
BMI   =   Body Mass Index 
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